[Clinical, radiological and endoscopic evaluation of the use of plasmutan in gastro-intestinal ulcerous diseases].
D000328:Adult; D000368:Aged; D000614:Aminocaproates / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D005756:Gastritis / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006551:Hernia, Hiatal / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy*
D000614:Aminocaproates; D004338:Drug Combinations; D005765:Gastrointestinal Agents; C011075:Plasmutan; D001729:Bismuth
Bilan clinique, radiologique et endoscopique de l'utilisation du Plasmutan au cours des affections ulcéreuses gastro-intestinales